373 related articles for article (PubMed ID: 21440331)
1. Environmental and clinical epidemiology of Aspergillus terreus: data from a prospective surveillance study.
Rüping MJ; Gerlach S; Fischer G; Lass-Flörl C; Hellmich M; Vehreschild JJ; Cornely OA
J Hosp Infect; 2011 Jul; 78(3):226-30. PubMed ID: 21440331
[TBL] [Abstract][Full Text] [Related]
2. A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates.
Blum G; Perkhofer S; Grif K; Mayr A; Kropshofer G; Nachbaur D; Kafka-Ritsch R; Dierich MP; Lass-Flörl C
Clin Microbiol Infect; 2008 Dec; 14(12):1146-51. PubMed ID: 19076844
[TBL] [Abstract][Full Text] [Related]
3. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
Kaya AD; Kiraz N
Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies.
Colozza C; Posteraro B; Santilli S; De Carolis E; Sanguinetti M; Girmenia C
Int J Antimicrob Agents; 2012 May; 39(5):440-3. PubMed ID: 22429723
[TBL] [Abstract][Full Text] [Related]
6. Molecular typing of Aspergillus terreus isolates by random amplification of polymorphic DNA.
Symoens F; Bouchara JP; Heinemann S; Nolard N
J Hosp Infect; 2000 Apr; 44(4):273-80. PubMed ID: 10772835
[TBL] [Abstract][Full Text] [Related]
7. [Possible sources of aspergilla infection in a hematological hospital].
Petrova NA; Kliasova GA
Ter Arkh; 2005; 77(7):71-7. PubMed ID: 16116914
[TBL] [Abstract][Full Text] [Related]
8. Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies.
Hachem RY; Kontoyiannis DP; Boktour MR; Afif C; Cooksley C; Bodey GP; Chatzinikolaou I; Perego C; Kantarjian HM; Raad II
Cancer; 2004 Oct; 101(7):1594-600. PubMed ID: 15378491
[TBL] [Abstract][Full Text] [Related]
9. Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.
Walsh TJ; Petraitis V; Petraitiene R; Field-Ridley A; Sutton D; Ghannoum M; Sein T; Schaufele R; Peter J; Bacher J; Casler H; Armstrong D; Espinel-Ingroff A; Rinaldi MG; Lyman CA
J Infect Dis; 2003 Jul; 188(2):305-19. PubMed ID: 12854088
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus.
Menotti J; Waller J; Meunier O; Letscher-Bru V; Herbrecht R; Candolfi E
J Hosp Infect; 2005 May; 60(1):61-8. PubMed ID: 15823659
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Aspergillus terreus at a university hospital.
Baddley JW; Pappas PG; Smith AC; Moser SA
J Clin Microbiol; 2003 Dec; 41(12):5525-9. PubMed ID: 14662934
[TBL] [Abstract][Full Text] [Related]
12. Molecular detection and identification of Aspergillus spp. from clinical samples using real-time PCR.
Ramírez M; Castro C; Palomares JC; Torres MJ; Aller AI; Ruiz M; Aznar J; Martín-Mazuelos E
Mycoses; 2009 Mar; 52(2):129-34. PubMed ID: 18643921
[TBL] [Abstract][Full Text] [Related]
13. Characterization of clinical strains of Aspergillus terreus complex: molecular identification and antifungal susceptibility to azoles and amphotericin B.
Escribano P; Peláez T; Recio S; Bouza E; Guinea J
Clin Microbiol Infect; 2012 Feb; 18(2):E24-6. PubMed ID: 22128886
[TBL] [Abstract][Full Text] [Related]
14. Aspergillus terreus complex.
Balajee SA
Med Mycol; 2009; 47 Suppl 1():S42-6. PubMed ID: 19291598
[TBL] [Abstract][Full Text] [Related]
15. Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants.
Lass-Flörl C; Rath P; Niederwieser D; Kofler G; Würzner R; Krezy A; Dierich MP
J Hosp Infect; 2000 Sep; 46(1):31-5. PubMed ID: 11023720
[TBL] [Abstract][Full Text] [Related]
16. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases].
Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B
Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification, phylogenetic analysis and antifungal susceptibility patterns of Aspergillusnidulans complex and Aspergillusterreus complex isolated from clinical specimens.
Mohamadnia A; Salehi Z; Namvar Z; Tabarsi P; Pourabdollah-Toutkaboni M; Rezaie S; Marjani M; Moniri A; Abtahian Z; Mahdaviani SA; Mortezaee V; Askari E; Sharifynia S
J Mycol Med; 2020 Sep; 30(3):101004. PubMed ID: 32534826
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology and Antifungal Susceptibility Profile of
Cho SY; Lee DG; Kim WB; Chun HS; Park C; Myong JP; Park YJ; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH
J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31018982
[TBL] [Abstract][Full Text] [Related]
20. Rep-PCR and RAPD-PCR fingerprinting of Aspergillus terreus.
Mutschlechner W; Grif K; Blum G; Lass-Flörl C
Med Mycol; 2013 Nov; 51(8):876-9. PubMed ID: 23758105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
